Ramipril and losartan are equal in preventing left ventricular systolic dysfunction in ST-elevation myocardial infarction patients treated by primary percutaneous coronary intervention

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Percutaneous Coronary ◽

Gender differences in the prognostic impact of chronic kidney disease in patients with left ventricular systolic dysfunction following ST elevation myocardial infarction treated with primary percutaneous coronary intervention

Hellenic Journal of Cardiology ◽

10.1016/j.hjc.2015.11.001 ◽

2016 ◽

Vol 57 (2) ◽

pp. 109-115 ◽

Cited By ~ 8

Author(s):

Lidija Savic ◽

Igor Mrdovic ◽

Milika Asanin ◽

Sanja Stankovic ◽

Gordana Krljanac ◽

...

Keyword(s):

Myocardial Infarction ◽

Chronic Kidney Disease ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Prognostic Impact ◽

Percutaneous Coronary ◽

Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial

European Journal of Heart Failure ◽

10.1002/ejhf.88 ◽

2014 ◽

Vol 16 (6) ◽

pp. 685-691 ◽

Cited By ~ 6

Author(s):

Javaid Iqbal ◽

Renaud Fay ◽

David Adlam ◽

Iain Squire ◽

Yasir Parviz ◽

...

Keyword(s):

Myocardial Infarction ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Post Myocardial Infarction ◽

Predictors of left ventricular systolic dysfunction after primary percutaneous coronary intervention for patients with left anterior descending artery occlusion

Journal of Medicine in Scientific Research ◽

10.4103/jmisr.jmisr_89_20 ◽

2021 ◽

Vol 4 (4) ◽

pp. 294

Author(s):

MohamedE L Bordy ◽

AhmedGalal A Fattah Fahmy

Keyword(s):

Systolic Dysfunction ◽

Coronary Intervention ◽

Artery Occlusion ◽

Left Ventricular ◽

Left Anterior Descending Artery ◽

Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: Insights from the VA CART Program

American Heart Journal ◽

10.1016/j.ahj.2021.02.002 ◽

2021 ◽

Author(s):

Todd J. Brophy ◽

Theodore J. Warsavage ◽

Annika L. Hebbe ◽

Mary E. Plomondon ◽

Stephen W. Waldo ◽

...

Keyword(s):

Coronary Artery Disease ◽

Stable Coronary Artery Disease ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Percutaneous Coronary ◽

Artery Disease

Effect of Upstream Doxycycline During Primary Percutaneous Coronary Intervention (PCI) for ST-Elevation Myocardial Infarction (STEMI) on Infarct Size and Left Ventricular (LV) Remodelling: the SALVAGE MI Randomised Trial

Heart Lung and Circulation ◽

10.1016/j.hlc.2021.06.473 ◽

2021 ◽

Vol 30 ◽

pp. S303-S304

Author(s):

S. Noaman ◽

C. Neil ◽

J. O'Brien ◽

M. Frenneaux ◽

J. Hare ◽

...

Keyword(s):

Myocardial Infarction ◽

Infarct Size ◽

Randomised Trial ◽

Coronary Intervention ◽

Left Ventricular ◽

St Elevation Myocardial Infarction ◽

Percutaneous Coronary ◽

Neutrophil to Lymphocyte Ratio Predicts Left Ventricular Remodeling in Patients with ST Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention

Korean Circulation Journal ◽

10.4070/kcj.2016.46.1.15 ◽

2016 ◽

Vol 46 (1) ◽

pp. 15 ◽

Cited By ~ 11

Author(s):

Abdurrezzak Börekçi ◽

Mustafa Gür ◽

Caner Türkoğlu ◽

Ahmet Oytun Baykan ◽

Taner Şeker ◽

...

Keyword(s):

Myocardial Infarction ◽

Ventricular Remodeling ◽

Left Ventricular Remodeling ◽

Coronary Intervention ◽

Left Ventricular ◽

Lymphocyte Ratio ◽

Percutaneous Coronary ◽

Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction

ESC Heart Failure ◽

10.1002/ehf2.12510 ◽

2019 ◽

Vol 6 (6) ◽

pp. 1233-1242 ◽

Cited By ~ 1

Author(s):

Adam D. DeVore ◽

Eric Yow ◽

Mitchell W. Krucoff ◽

Matthew W. Sherwood ◽

Linda K. Shaw ◽

...

Keyword(s):

Coronary Disease ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention and Abciximab or Tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2008.11.029 ◽

2009 ◽

Vol 103 (6) ◽

pp. 785-790 ◽

Cited By ~ 6

Author(s):

Nevio Taglieri ◽

Francesco Saia ◽

Vincenzo Guiducci ◽

Stefano Tondi ◽

Federico Conrotto ◽

...

Keyword(s):

Myocardial Infarction ◽

Left Ventricular Function ◽

Ventricular Function ◽

Coronary Intervention ◽

Left Ventricular ◽

St Elevation Myocardial Infarction ◽

Percutaneous Coronary ◽

Impact of Lipoprotein (a) Levels on Long-Term Outcomes Following Percutaneous Coronary Intervention in Patients With Left Ventricular Systolic Dysfunction

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2017.08.373 ◽

2017 ◽

Vol 23 (10) ◽

pp. S74

Author(s):

Jun Shitara ◽

Hirokazu Konishi ◽

Takatoshi Kasai ◽

Katsumi Miyauchi ◽

Shuta Tsuboi ◽

...

Keyword(s):

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Long Term Outcomes ◽

Lipoprotein A ◽

Protected percutaneous coronary intervention with Impella CP in a patient with left main disease, severe left ventricular systolic dysfunction and established hemolysis

Cardiovascular Diagnosis and Therapy ◽

10.21037/cdt.2019.02.06 ◽

2019 ◽

Vol 9 (2) ◽

pp. 194-199 ◽

Cited By ~ 2

Author(s):

Klio Konstantinou ◽

Thomas R. Keeble ◽

Paul A. Kelly ◽

Osama Alsanjari ◽

L. Christian Napp ◽

...

Keyword(s):

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Left Main ◽

Left Main Disease ◽